Abstract:Aim(s) To systematically review the existing literature and address the following research question: What are the most effective techniques used to minimise adverse effects resulting from subcutaneous injections of low‐molecular‐weight heparin among patients with cardiovascular diseases? Design A scoping review. Methods A comprehensive search was conducted across multiple databases, including CINAHL, PubMed, EMBASE and the Cochrane Library, from 1 February 2014 to 31 January 2024. Participants were aged 18 years or older, diagnosed with venous thromboembolism or arterial thromboembolism and had prescribed subcutaneous injections of low‐molecular‐weight heparin. The collected data were analysed following the Joanna Briggs Institute approach, and it was organised and categorised based on the main objectives of the review. Results Twenty studies were eligible, including 1 best practice project, 7 randomised controlled trials and 9 quasi‐experimental studies. The techniques under investigation encompassed various aspects, including the injection site, injection duration (e.g., 30 s vs. 10 s), injection method (e.g., needle insertion angle), duration of needle withdrawal after injection, pressure application time and cold pressure. Preliminary evidence suggests that techniques such as using the abdominal site and slower injection rates may help reduce adverse effects. However, the optimal parameters for injection duration, waiting time, pressure and cold application, including the duration of these applications, remain uncertain due to limitations in sample size and heterogeneity in interventions and outcome measures across the studies. Conclusions Ensuring the accurate administration of low‐molecular‐weight heparin is of utmost importance as it plays a critical role in decreasing mortality rates and minimising substantial healthcare costs linked to complications arising from incorrect administration. The findings from the current review have significantly contributed to strengthening the evidence base in this field, providing more robust and reliable information. Implications for the Profession This review emphasises the significance of implementing standardised subcutaneous injection techniques for low‐molecular‐weight heparin in patients with cardiovascular disease in order to reduce complications and enhance patient outcomes. Reporting Method This study followed the applicable guidelines established by the PRISMA 2020 statement. The PRISMA checklist for systematic reviews was utilised for reporting purposes. Patient or Public Contribution There is no patient or public contribution to declare. Trial Registration OSF registries: osf.io/phk72

Prevalence and in vitro Antifungal Susceptibility Pattern of Candida species in a Tertiary Care Hospital, Rawalpindi, Pakistan

Changes in Coagulation and Fibrinolysis in Post-Cesarean Section Parturients Treated With Low Molecular Weight Heparin

[Aphasia-producing lesions using X-CT, MRI-CT and positron emission CT].

Examining postpartum anticoagulation practices: An international survey of healthcare providers

The laboratory control of anticoagulant thromboprophylaxis during the early postpartum period after cesarean delivery

Multimode resonances in silver nanocuboids.

Postpartum thromboprophylaxis with enoxaparin: a prospective cohort study on patients' adherence, injection experience, and information retention after counselling by pharmacists

Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study

[Post-partum management after cesarean delivery. Guidelines for clinical practice]

Applying PBL and SRL to Enhance Learning Strategies and Collaboration in a Blended Learning Environment

Low-dose low-molecular-weight heparin prophylaxis against obstetrical complications in pregnancies with metabolic and immunological disorder-associated placental inflammation

Short title : Threatened abortion outcome during anticoagulation treatment Outcomes of threatened abortions after anticoagulation treatment to prevent recurrent pregnancy loss 5

Factors influencing patient's perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study

Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation

A History of Cesarean Birth as a Risk Factor for Postpartum Hemorrhage Even After Successful Planned Vaginal Birth

[Prophylactic Use of Low Molecular Weight Heparin in Combination with Graduated Compression Stockings in Post-Operative Patients with Gynecologic Cancer].

Role of thyroid in tissue respiration of birds.

Use of the Delphi method to facilitate antithrombotics prescription during pregnancy

Injection Techniques to Reduce Adverse Effects of Subcutaneous Low‐Molecular‐Weight Heparin Among Patients With Cardiovascular Diseases: A Scoping Review

Study To Reduce Infection Prior to Elective Cesarean Deliveries (STRIPES): a randomized clinical trial of chlorhexidine

Multiple forms of starch branching enzyme of maize: evidence for independent genetic control.